Alliancebernstein L.P. Sells 3,472,895 Shares of Astera Labs, Inc. $ALAB

Alliancebernstein L.P. trimmed its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 54.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,918,685 shares of the company’s stock after selling 3,472,895 shares during the period. Alliancebernstein L.P. owned 1.73% of Astera Labs worth $571,479,000 as of its most recent SEC filing.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company’s stock valued at $2,690,907,000 after buying an additional 1,693,918 shares during the period. State Street Corp lifted its holdings in Astera Labs by 39.3% in the second quarter. State Street Corp now owns 2,143,459 shares of the company’s stock worth $193,812,000 after buying an additional 604,363 shares during the period. 1832 Asset Management L.P. lifted its holdings in Astera Labs by 151.4% in the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares during the period. Massachusetts Financial Services Co. MA boosted its position in Astera Labs by 46.6% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 1,507,675 shares of the company’s stock valued at $295,203,000 after acquiring an additional 479,360 shares in the last quarter. Finally, Amundi boosted its position in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after acquiring an additional 1,319,643 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of Astera Labs stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the completion of the transaction, the chief operating officer owned 1,531,301 shares in the company, valued at approximately $189,590,376.81. The trade was a 5.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jack R. Lazar sold 7,500 shares of the business’s stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $119.80, for a total value of $898,500.00. Following the completion of the sale, the director directly owned 87,351 shares in the company, valued at $10,464,649.80. This trade represents a 7.91% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 224,292 shares of company stock worth $27,676,069 over the last quarter. 12.50% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

ALAB has been the topic of a number of research analyst reports. Citigroup reduced their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a report on Wednesday, February 11th. BNP Paribas Exane started coverage on Astera Labs in a research note on Thursday, November 20th. They issued an “outperform” rating for the company. Morgan Stanley restated an “overweight” rating and set a $210.00 price target on shares of Astera Labs in a research report on Wednesday, December 3rd. Raymond James Financial initiated coverage on Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating on the stock. Finally, Weiss Ratings downgraded Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $202.22.

Astera Labs Stock Performance

Shares of NASDAQ ALAB opened at $120.31 on Friday. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The company has a 50 day simple moving average of $147.89 and a two-hundred day simple moving average of $168.11. The company has a market capitalization of $20.48 billion, a price-to-earnings ratio of 98.61, a P/E/G ratio of 2.37 and a beta of 1.74.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The business’s revenue was up 91.8% on a year-over-year basis. During the same period last year, the business earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.